Our initial studies described the synthesis and reactivity
of aziridine-fused N-Mbs-[1,2,3,6]oxathiadiazinane-2,
2-dioxide heterocycles, which were found, in select cases,
to undergo nucleophilic ring-opening with modest effi-
ciency (Figure 2a).7ꢀ9 Studies to further optimize these
addition reactions and to determine the origin of material
lossledus toconcludethataziridine displacementoccurred
with little regiocontrol. The intermediate generated from
nucleophilic attack at C7 was, however, unstable to the
reaction conditions and decomposed to liberate MbsNH2.
A series of control experiments using oxathiadiazinane 210
demonstrated that base additives (e.g., KN(SiMe3)2, pyr-
idine, or NaH) would promote rapid ring fragmentation
(Figure 2b). The unusual and unprecedented reactivity of
the N-Mbs oxathiadiazinane heterocycle has no obvious
explanation. We speculated that replacing the N4-Mbs
group with an acyl substituent might mitigate the decom-
position of these heterocycles by influencing the ring
conformation. Such an alteration would present new
challenges for substrate synthesis and would likely affect
the oxidative cyclization reaction; however, the ease of
removing the N4-acyl group as compared to the Mbs-
would be advantageous for the overall utility of the
method. Accordingly, N-Boc and N-Troc substrates were
targeted with these considerations in mind.
These sulfamate derivatives engage in either Mitsunobu or
asymmetric π-allyl Pd-coupling reactions with alcohol or
carbonate starting materials, respectively. The Troc-re-
agent 3, in particular, operates with superior performance
in both types of displacement reactions when compared to
either 4 or the Mbs-variant. As shown in Figure 3, Pd-
catalyzed π-allylation of 3 using carbonate 7 gives the R,
R-disubstituted sulfamate in high yield and with excellent
regiocontrol (>20:1 branched/linear product). The analo-
gous reaction utilizing 4 proceeds in modest yield
while the same reaction, when performed with MbsNHO-
SO2NH2, fails to give any allylated product. In light of
these findings, most of our subsequent investigations have
been conducted with the N-Troc sulfamate reagent 4. The
identification of this sulfamate derivative should markedly
facilitate access to a range of substituted oxathiadiazinane
heterocycles and thus 1,2- and 1,3-diamine products.
Figure 3. N-Carbamoyl sulfamate reagents perform optimally in
allylation reactions.
Intramolecular aziridination reactions with both Boc-
and Troc-derived sulfamates are highlighted in Table 1. In
general, cyclizations performed optimally using a dinuc-
lear tetracarboxylate rhodium catalyst (2 mol %), PhI-
(OAc)2, and MgO.11 Oxidations occur smoothly in
isopropyl acetate, which proves more effective as a solvent
than others typically employed for Rh-catalyzed amina-
tion (e.g., CH2Cl2, benzene).12 Olefinic substitution does
not have a large influence on the reaction as terminal
(entries 1 and 2), disubstituted (entries 3 and 4), and
trisubstituted (entry 5) alkenes are all converted in
high yields to the corresponding bicyclic aziridines.
While product yields of N-Boc substrates were slightly
depressed, those of N-Troc substrates were excellent
and comparable to the performance of analogous N-Mbs
substrates.2,6
Figure 2. Unusual base-promoted decomposition of Mbs-sub-
stituted oxathiadiazinanes. Mbs = p-methoxybenzenesulfonyl.
Synthesis of TrocNHOSO2NH2 3 and BocNHO-
SO2NH2 4 is easily accomplished in two steps from hydrox-
ylamine. Both reagents are crystalline and can be pre-
paredon >10 g scalewithoutrecourse to chromatography.
(7) We refer to these heterocycles as oxathiadiazinanes for simplicity.
(8) Prior to our work, we are only aware of one report of these
heterocycles; see: Arfaei, A.; Smith, S. J. Chem. Soc., Perkin Trans. 1
1984, 1791–1794.
(9) For the synthesis and reactivity of related aziridine-fused oxathia-
zinanes, see: (a) Wehn, P. M.; Du Bois, J. Angew. Chem. 2009, 121, 3860–
3863. (b) Guthikonda, K.; Wehn, P. M.; Caliando, B. J.; Du Bois, J.
Tetrahedron 2006, 62, 11331–11342. (c) Wehn, P. M.; Lee, J.; Du Bois, J.
Org. Lett. 2003, 5, 4823–4826. (d) Duran, F.; Leman, L.; Ghini, A.;
Burton, G.; Dauban, P.; Dodd, R. H. Org. Lett. 2002, 4, 2481–2483.
(10) Compound 2 was prepared using Rh-catalyzed CꢀH amination;
see ref 6.
(11) Rh2(esp)2 is sold by Aldrich Chemical Co. as Rh2(R,R,R0,
R0-tetramethyl-1,3-benzenedipropionate)2. For the initial report of this
catalyst, see: Espino, C. G.; Fiori, K. W.; Kim, M.; Du Bois, J. J. Am.
Chem. Soc. 2004, 126, 15378–15379.
(12) The use of i-PrOAc was prompted by a previous report describ-
ing aldehyde CꢀH sulfamidation; see: Chan, J.; Baucom, K. D.; Murry,
J. A. J. Am. Chem. Soc. 2007, 129, 14106–14107.
Org. Lett., Vol. 13, No. 13, 2011
3337